Page 7 of 8
ACS Medicinal Chemistry Letters
7. Takeuchi, O.; Akira, S. Pattern recognition receptors and
Yang, R.; Torres, L.; Zhang-Hoover, J.; Northrup, A.
Identification of quinazoline based inhibitors of IRAK4 for the
treatment of inflammation. Bioorg. Med. Chem. Lett. 2017, 27,
2721–2726.
inflammation. Cell, 2010, 140, 805–820.
1
2
3
4
5
6
7
8
8. Ohl, K.; Tenbrock, K. J. Inflammatory cytokines in systemic
lupus erythematosus. Biomed. Biotechnol. 2011, 2011, 432595:
1–14.
12. McElroy, W. T. Interleukin-1 receptor-associated kinase 4
(IRAK4) inhibitors: an updated patent review (2016-2018).
Expert Opin. Ther. Pat. 2019, 29, 243-259.
9. Lee, K. L.; Ambler, C. M.; Anderson, D. R.; Boscoe, B. P.; Bree,
A. G.; Brodfuehrer, J. I.; Chang, J. S.; Choi, C.; Chung, S.;
Curran, K. J.; Day, J. E.; Dehnhardt, C. M.; Dower, K.; Drozda,
S. E.; Frisbie, R. K.; Gavrin, L. K.; Goldberg, J. A.; Han, S.;
Hegen, M.; Hepworth, D.; Hope, H. R.; Kamtekar, S.; Kilty, I. C.;
Lee, A.; Lin, L.-L.; Lovering, F. E.; Lowe, M. D.; Mathias, J. P.;
Morgan, H. M.; Murphy, E. A.; Papaioannou, N.; Patny, A.;
Pierce, B. S.; Rao, V. R.; Saiah, E.; Samardjiev, I. J.; Samas, B.
M.; Shen, M. W. H.; Shin, J. H.; Soutter, H. H.; Strohbach, J. W.;
Symanowicz, P. T.; Thomason, J. R.; Trzupek, J. D.; Vargas, R.;
Vincent, F.; Yan, J.; Zapf, C. W.; Wright, S. W. Discovery of
13. Bryan, M. C.; Drobnick, J.; Gobbi, A.; Kolesnikov, A.; Chen, Y.;
Rajapaksa, N.; Ndubaku, C.; Feng, J.; Chang, W.; Francis, R.; Yu,
C.; Choo, E. F.; DeMent, K.; Ran, Y.; An, L.; Emson, C.; Huang,
Z.; Sujatha-Bhaskar, S.; Brightbill, H.; DiPasquale, A.; Maher, J.;
Wai, J.; McKenzie, B. S.; Lupardus, P. J.; Zarrin, A. A.; Kiefer,
J. R. Development of Potent and Selective Pyrazolopyrimidine
IRAK4 Inhibitors. J. Med. Chem. 2019, 62, 6223-6240.
14. Fitzgerald-Bocarsly, P.; Dai, J.; Singh, S. Plasmacytoid dendritic
cells and type I IFN: 50 years of convergent history. Cytokine
Growth Factor Rev. 2008, 19, 3–19.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
clinical
candidate
1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-
oxopyrrolidin2-yl]methoxy}-7-methoxyisoquinoline-6-
carboxamide (PF06650833), a potent, selective inhibitor of
interleukin-1 receptor associated kinase 4 (IRAK4), by fragment-
based drug design. J. Med. Chem. 2017, 60, 5521–5542.
15. Van, L. P.; Bardel, E.; Gregoire, S.; Vanoirbeek, J.; Schneider, E.;
Dy, M.; Thieblemont, N. Treatment with the TLR7 agonist R848
induces regulatory T-cell-mediated suppression of established
asthma symptoms. Eur. J. Immunol. 2011, 41, 1992–1999.
16. Genung, N. E.; Guckian, K. M. Small molecule inhibition of
interleukin-1 receptor-associated kinase 4 (IRAK4). Prog. Med.
Chem., 2017, 56, 117–163.
17. Lim, J.; Altman, M. D.; Baker, J.; Brubaker, J. D.; Chen, H.;
Chen, Y.; Fischmann, T.; Gibeau, C.; Kleinschek, M. A.; Leccese,
E.; Lesburg, C.; Maclean, J. K. F.; Moy, L. Y.; Mulrooney, E. F.;
Presland, J.; Rakhilina, L.; Smith, G. F.; Steinhuebel, D.; Yang,
R. Discovery of 5-amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-
a]pyrimidine-3-carboxamide inhibitors of IRAK4. ACS Med.
Chem. Lett. 2015, 6, 683–688.
10. Dudhgaonkar, S.; Ranade, S.; Nagar, J.; Subramani, S.; Prasad, D.
S.; Karunanithi, P.; Srivastava, R.; Venkatesh, K.; Selvam, S.;
Krishnamurthy, P.; Mariappan, T. T.; Saxena, A.; Fan, L.;
Stetsko, D. K.; Holloway, D. A.; Li, X.; Zhu, J.; Yang, W.-P.;
Ruepp, S.; Nair, S.; Santella, J.; Duncia, J.; Hynes, J.; McIntyre,
K. W.; Carman, J. A. Selective IRAK4 inhibition attenuates
disease in murine lupus models and demonstrates steroid sparing
activity. J. Immunol. 2017, 198, 1308–1319.
11. Smith, G. F.; Altman, M. D.; Andresen, B.; Baker, J.; Brubaker,
J. D.; Chen, H.; Chen, Y.; Childers, M.; Donofrio, A.; Ferguson,
H.; Fischer, C.; Fischmann, T. O.; Gibeau, C.; Hicks, A.; Jin, S.;
Kattar, S.; Kleinschek, M. A.; Leccese, E.; Lesburg, C.; Li, C.;
Lim, J.; Liu, D.; Maclean, J. K. F.; Mansoor, F.; Moy, L. Y.;
Mulrooney, E. F.; Necheva, A. S.; Presland, J.; Rakhilina, L.;
18. (18) Turner, M. D.; Nedjai, B.; Hurst, T.; Pennington, D. J.
Cytokines and chemokines: At the crossroads of cell signalling
and inflammatory disease. Biochim. Biophys. Acta. 2014, 1843,
2563–2582.
ACS Paragon Plus Environment